AVE 50.0% 0.3¢ avecho biotechnology limited

what's next for 2012???

  1. 1,912 Posts.
    lightbulb Created with Sketch. 214
    "" indicate quotes taken from announcements

    February 24 2012 - Annual Prelim Report
    1st Quarter - 2nd Largist Global Pharma deal
    1st Quarter - "Phosphagenics and the dermatology company will discuss commercial arrangements for the final product upon trial completion, expected 4th quarter 2011"
    1st Quarter - "a new range of high end shampoos, conditioners, hair serums and intensive treatments on shelves in US stores and exclusive salons in the first quarter of 2012"

    3rd Quarter - Hopes to launch in Elixia in US - "Esra said on sky wanted to establish a retail chain.

    4th Quarter - Phase 111 Trials for Oxycodene
    4th Quarter - Thermis Medical to deliver an over the counter diclofenac product

    Ongoing - Animal Insulin

    When ready -
    Insulin patch update Dec 2009 " “We are now perfectly placed to start clinical trials on the TPM/insulin patch system in first half of next year,”
    Lemetier - A proper update I would like to see some numbers
 
watchlist Created with Sketch. Add AVE (ASX) to my watchlist
(20min delay)
Last
0.3¢
Change
0.001(50.0%)
Mkt cap ! $9.508M
Open High Low Value Volume
0.3¢ 0.3¢ 0.3¢ $13.04K 5.204M

Buyers (Bids)

No. Vol. Price($)
51 98339032 0.2¢
 

Sellers (Offers)

Price($) Vol. No.
0.3¢ 20969054 12
View Market Depth
Last trade - 16.10pm 27/06/2024 (20 minute delay) ?
AVE (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.